• 2015

    first collaborations in the veterinary vaccine field

  • 2014

    SUN Global FZE as strategic investor

  • 2013

    bio-similar tech transfers to Vietnam, Thailand and Indonesia

  • 2012

    first collaborations in the area VLP based vaccines

  • 2011

    first bio-similar technology transfers & establishment of secretory E. coli platform

  • 2010

    acquisition of the patent family „VLP vaccines“

  • 2008

    establishment of process development group, second chaperone patent

  • 2007

    move in facility in Langenfeld (850 sqm labs and offices)

  • 2006

    first patent granted (chaperone)

  • 2002

    foundation as contract R&D company and first license deals